We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.27 | 0.18% | 148.80 | 1,870 | 12:51:44 |
From Apr 2021 to Apr 2024
By Tarini Parti
President Biden said his administration was working with officials at Pfizer Inc., Moderna Inc. and Johnson & Johnson to develop contingency plans for vaccines or boosters in case they are needed to combat the Omicron variant of the coronavirus.
Mr. Biden said at this time officials don't think such additional measures will be needed.
He also said he will soon release a strategy outline for how the administration plans to deal with Covid-19 this winter, adding that the plans would focus on more vaccinations, boosters and testing rather than lockdowns.
"This variant is a cause for concern, not a cause for panic," he said.
Write to Tarini Parti at tarini.parti@wsj.com
(END) Dow Jones Newswires
November 29, 2021 12:51 ET (17:51 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
